Rapid Micro Biosystems announced an underwritten offering priced at $9.8 million, selling shares and warrants that could raise up to $32 million if all warrants are exercised. Investors include Bain Capital Life Sciences and Armistice Capital. The offering includes Class A common stock and pre-funded warrants with accompanying Series A and B warrants exercisable at set prices and timeframes. Proceeds will support the company's growth in life sciences automation technology, with the offering expected to close on May 20, 2026, pending customary conditions.
Rosen Law Firm has announced an investigation into potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. This legal action could impact shareholders of the company, signaling possible misconduct at the man...
Japan's bond market is under severe pressure with 30-year government bond yields surpassing 4%, the highest since 1999, sparking fears of global financial instability. This turmoil threatens to impact interest rates, currencies, and credit markets wo...
David Schwartz, Ripple's former CTO, criticized the hype around the FUZZY meme coin on the XRP Ledger, calling meme coin investments "distasteful." He clarified that opening a trust line for FUZZY was a technical action, not an endorsement, and stres...
Bitcoin recovered to nearly $77,000 after US President Donald Trump paused a planned military strike on Iran following requests from Gulf leaders for diplomatic talks. This decision sparked optimism in global markets, lifting Bitcoin and traditional ...
American Bitcoin Corp., backed by the Trump family, saw its stock fall over 9% following a quarterly net loss of nearly $82 million. The company increased its Bitcoin holdings to about 7,500 BTC, making it the 15th largest public Bitcoin treasury glo...
